NR2F2 and breast carcinoma: In 119 human breast cancer patients, fifty-nine percent of the specimens are immunohistochemically positive for COUP-TFII, and COUP-TFII expression level positively correlates with a poor clinical stage, lymph node status, histological grade and estrogen receptor alpha status[25].